DEFINING TREATMENT AIMS AND END-POINTS IN OLDER PATIENTS WITH CANCER

被引：3
|
作者：
DESCH, CE
SMITH, TJ
机构：
[1] Department of Medicine, Division of Hematology/Oncology, Massey Cancer Center, Virginia Commonwealth University/Medical College of Virginia, Richmond, Virginia, 23298-0037, 401 College Street
来源：
DRUGS & AGING | 1995年 / 6卷 / 05期
关键词：
D O I：
10.2165/00002512-199506050-00002
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
[No abstract available]
引用
收藏
页码：351 / 357
页数：7
相关论文
共 50 条
  • [1] ACHIEVABLE GOALS AND RELEVANT END-POINTS IN CANCER-TREATMENT
    TATTERSALL, MHN
    CANCER DETECTION AND PREVENTION, 1990, 14 (06): : 679 - 681
  • [2] End-points for drug treatment in NASH
    Leon A. Adams
    Hepatology International, 2019, 13 : 253 - 258
  • [3] End-points for drug treatment in NASH
    Adams, Leon A.
    HEPATOLOGY INTERNATIONAL, 2019, 13 (03) : 253 - 258
  • [4] RENAL END-POINTS IN NONDIABETIC PATIENTS
    OLDRIZZI, L
    RUGIU, C
    DEBIASE, V
    MASCHIO, G
    KIDNEY INTERNATIONAL, 1994, 45 : S118 - S120
  • [5] BENIGN BREAST DISEASE - END-POINTS OF TREATMENT
    FORREST, AP
    CANCER DETECTION AND PREVENTION, 1992, 16 (01): : 61 - 65
  • [6] Correction to: End-points for drug treatment in NASH
    Leon A. Adams
    Hepatology International, 2019, 13 (3) : 259 - 259
  • [7] SURROGATE END-POINTS
    ELLENBERG, SS
    BRITISH JOURNAL OF CANCER, 1993, 68 (03) : 457 - 459
  • [8] Clinically meaningful end-points: Long term survival end-points versus early time to event based end-points
    Pignatti, F.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S18 - S18
  • [9] MEDICAL END-POINTS
    MCGREGOR, DD
    BENJAMIN, RB
    BERENDES, HW
    BERNSTEIN, GS
    COULSON, AH
    CROZIER, R
    EMSLANDER, RF
    QUIROGA, J
    SCHMIDT, S
    SCHUMAN, LM
    SULLIVAN, T
    JOURNAL OF CLINICAL EPIDEMIOLOGY, 1993, 46 (08) : 753 - 768
  • [10] SURROGATE END-POINTS
    BOUVENOT, G
    REVUE DU RHUMATISME, 1994, 61 (11): : 711 - 713
12345